The Rosen Law Firm, a global investor rights law firm, announced a securities fraud class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD). The firm alleges that LifeMD made misleading statements to investors between May 7, 2025, and August 5, 2025.
The lawsuit claims LifeMD overstated its competitive standing and was reckless in its 2025 financial projections. Specifically, the complaint alleges the company failed to account for increased customer acquisition costs related to its RexMD segment and the sale of obesity treatment drugs like Wegovy and Zepbound.
These allegedly false statements, according to the Rosen Law Firm, caused investors to suffer financial losses when the truth emerged. The firm is seeking compensation for those who purchased LifeMD securities during the specified period.
Investors who meet the criteria have until October 27, 2025, to apply to the court to become lead plaintiff. A lead plaintiff represents the interests of all class members in the litigation. The Rosen Law Firm emphasizes the importance of selecting experienced legal counsel with a proven track record in securities class action lawsuits.
The Rosen Law Firm highlighted its extensive experience in representing investors globally, particularly in securities class actions and shareholder derivative litigation. The firm cited past successes, including securing the largest-ever securities class action settlement against a Chinese company at the time and consistently ranking among the top firms for securities class action settlements.
The firm’s attorneys have received numerous accolades and recognitions within the legal profession. Laurence Rosen, the firm’s founding partner, was named a Titan of the Plaintiffs’ Bar by Law360. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
Potential class members can contact Phillip Kim, Esq. at the Rosen Law Firm for more information about the class action lawsuit. The firm emphasizes that no class has yet been certified, and individuals have the right to choose their own counsel or remain absent class members. Participation in any potential recovery does not depend on serving as lead plaintiff.
Related
